GLPBio

Meloxicam (Mobic)

Catalog No.: GC11762Purity:>99.50%Synonyms: UHAC 62XX
Meloxicam (Mobic) は非ステロイド性抗炎症剤であり、COX 活性を阻害し、COX-2 および COX-1 の IC50 はそれぞれ 0.49 μM および 36.6 μM です。

製品は研究用途にのみ使用できます。人体には使用できません。患者への販売は行っておりません。


Meloxicam (Mobic)
Cas No.: 71125-38-7
10mM (in 1mL DMSO)In Stock
$26.00
1
100mgIn Stock
$25.00
1
500mgIn Stock
$60.00
1

引用文献 (Citations)

現在、この製品の引用文献はありません。以下はGlpBio製品を引用した代表的な文献です。
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

製品説明 (Description)

Meloxicam (Mobic) is a piroxicam-class nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic effects. Meloxicam inhibits COX-2 and reduces prostaglandin synthesis. Meloxicam is used for osteoarthritis, rheumatoid arthritis and related inflammatory pain research[1-4].

In vitro, HT-29 cells were treated with 100-800μM Meloxicam for 24-72 hours. Meloxicam decreased cell proliferation, arrested the cell cycle. Meloxicam reduced VEGF and Ang-2 protein levels in culture supernatant[5]. A549 cells were treated with 0.1mg/mL Meloxicam for 48 hours. Meloxicam decreased cell proliferation activity, reduced LPS-stimulated IL-6 protein secretion[6]. Raji cells were treated with 6.25-200μM Meloxicam for 24 hours. Meloxicam decreased cell viability. Meloxicam induced cell apoptosis[7].

In vivo, diet-induced obese C57BL/6J mice received daily intraperitoneal injection of 10mg/kg Meloxicam for 2 days. Meloxicam increased hepatocyte EGFR and PCNA expression, reduced hepatic fatty vacuolar changes and glycogen storage[8]. Swiss-Webster mice received a single intraperitoneal injection of 60mg/kg Meloxicam at 24 hours after splenectomy. Meloxicam maintained sucrose preference, reduced GFAP reactivity and CD45 microglial inflammation in the hippocampus, piriform cortex and hypothalamus[9]. ICR mice received daily subcutaneous injection of 20mg/kg Meloxicam for 3 or 7 days. Meloxicam caused fecal occult blood, induced gastric lesions including gastritis and mucosal ulceration[10].

References:
[1] Noble S, Balfour JA. Meloxicam. Drugs. 1996 Mar;51(3):424-30; discussion 431-32.
[2] Blair HA. Bupivacaine/Meloxicam Prolonged Release: A Review in Postoperative Pain. Drugs. 2021 Jul;81(10):1203-1211.
[3] Khalil NY, Aldosari KF. Meloxicam. Profiles Drug Subst Excip Relat Methodol. 2020;45:159-197.
[4] White C, Morrow L. Efficacy of meloxicam compared with carprofen for treating canine osteoarthritis. Vet Rec. 2020 Jan 25;186(3):94.
[5] Zhang Ning, Tao Kaixiong, Huang Tao. Effects of Meloxicam on Vascular Endothelial Growth Factor and Angiopoietin-2 Expression in Colon Carcinoma Cell Line HT-29. J Huazhong Univ Sci Technol Med Sci. 2007;27(4):399-402.
[6] Party P, Kokai D, Burian K, et al. Development of extra-fine particles containing nanosized meloxicam for deep pulmonary delivery: In vitro aerodynamic and cell line measurements. Eur J Pharm Sci. 2022;176:106247.
[7] Asmarani YK, Supriatno, Haniastuti T. Effect of Meloxicam on the Proliferation and Apoptosis of the Raji Cell Line: an In Vitro Study. International Journal of Dentistry. 2022;2022:9579326.
[8] Jin X, Zimmers TA, Jiang Y, et al. Meloxicam Increases EGFR Expression Improving Survival following Hepatic Resection in Diet-induced Obese Mice. Surgery. 2018 Jun;163(6):1264-1271.
[9] Haile M, Boutajangout A, Chung K, et al. The Cox-2 Inhibitor Meloxicam Ameliorates Neuroinflammation and Depressive Behavior in Adult Mice after Splenectomy. J Neurophysiol Neurol Disord. 2016;3.
[10] Kendall LV, Bailey AL, Singh B, et al. Toxic Effects of High-dose Meloxicam and Carprofen on Female CD1 Mice. J Am Assoc Lab Anim Sci. 2022 Jan;61(1):75-80.

実験プロトコル (Protocol)

Cell experiment [1]:

Cell lines

Raji cells (human Burkitt lymphoma cell line)

Preparation Method

Raji cells were treated with Meloxicam at 6.25-200μM for 24 hours, then cell viability was assessed by MTT assay, apoptosis was assessed by flow cytometry after 100 and 200μM treatment, and cell morphology was observed by scanning electron microscopy.

Reaction Conditions

6.25-200μM; 24h

Applications

Meloxicam decreased cell viability, increased cell apoptosis in a dose-dependent manner. Meloxicam caused cytoplasmic blebbing and foamy morphology.
Animal experiment [2]:

Animal models

ICR mice

Preparation Method

Female Crl:CD1(ICR) mice were subcutaneously administered Meloxicam at 20mg/kg every 24 hours for 3 days or 7 days, then euthanized at day 4 or day 8; one 7-day cohort was allowed 7 days recovery and euthanized at day 15. Serum chemistry was analyzed, fecal occult blood was tested, and stomach/duodenum/ileum/cecum/colon tissues were collected for histopathology.

Dosage form

20mg/kg; s.c.; daiy for 3 or 7 days

Applications

Meloxicam produced fecal occult blood and gastritis with neutrophilic infiltrates and mucosal ulceration in ICR mice. Meloxicam caused lower albumin and ALP or globulin changes in serum chemistry.

References:
[1] Asmarani YK, Supriatno, Haniastuti T. Effect of Meloxicam on the Proliferation and Apoptosis of the Raji Cell Line: an In Vitro Study. International Journal of Dentistry. 2022;2022:9579326.
[2] Kendall LV, Bailey AL, Singh B, et al. Toxic Effects of High-dose Meloxicam and Carprofen on Female CD1 Mice. J Am Assoc Lab Anim Sci. 2022 Jan;61(1):75-80.

製品資料 (Product Documents)

Purity:>99.50%Appearance:A solid

化学的性質 (Chemical Properties)

CAS番号
71125-38-7
同義語
UHAC 62XX
化学名
4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1λ6,2-benzothiazine-3-carboxamide
SMILES
CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O
分子式
C14H13N3O4S2
分子量
351.4
溶解性
≥ 17.57mg/mL in DMSO
保存条件
Store at -20°C
配送条件
評価用サンプルは保冷剤とともに発送します。その他の容量は室温で発送し、ご要望に応じて保冷剤を同梱します。

計算ツール (Calculators)モル濃度 / 希釈 / 分子量 / 単位変換 / in vivo製剤 / 溶解度

g/mol

Reviews

Review for Meloxicam (Mobic)

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%